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The expressionofgeneswith key roles indevelopment is under very tight spatial
and temporal control, mediated by enhancers. A classic example of this is the
sonic hedgehog gene (Shh), which plays a pivotal role in the proliferation, differ-
entiation and survival of neural progenitor cells both in vivo and in vitro. Shh
expression in the brain is tightly controlled by several known enhancers that
have been identified through genetic, genomic and functional assays. Using
chromatin profiling during the differentiation of embryonic stem cells to
neural progenitor cells, here we report the identification of a novel long-range
enhancer for Shh—Shh-brain-enhancer-6 (SBE6)—that is located 100 kb
upstream of Shh and that is required for the proper induction of Shh expression
during this differentiation programme. This element is capable of driving
expression in the vertebrate brain. Our study illustrates how a chromatin-
focused approach, coupled to in vivo testing, can be used to identify new
cell-type specific cis-regulatory elements, and points to yet further complexity
in the control of Shh expression during embryonic brain development.1. Introduction
Enhancers orchestrate the regulation of gene expression, which is critical for cell
lineage specification and differentiation, and they therefore have a pivotal role
during embryonic development [1]. Awell-defined example of such cis-regulatory
control is seen in the case of the sonic hedgehog (Shh) gene. Shh encodes a secreted
signalling protein that imparts patterns of growth and identity to cells during
many stages of embryonic development, including neural progenitors throughout
ventral regions of the developing central nervous system (CNS) [2–4] (figure 1a).
Shh is located at one end of a large (approx. 1 Mb) regulatory domain contain-
ing a number of known enhancers controlling various Shh expression domains
[5–12] (figure 1b). Precise Shh expression is critical for proper spinal cord and
brain development, and this is governed by a subset of floor-plate and brain
enhancers, many of which were identified by reporter assays. Shh floor-plate
enhancer SFPE1, located 8 kb upstream of the Shh transcription start site (TSS),
drives expression in the ventral spinal cord, and SFPE2 and Shh-brain-enhancer
1 (SBE1), positioned in the second intron of Shh, show activity in the floor plate of
the spinal cord, as well as the ventral midbrain (mesencephalon), ventroposterior
region of the diencephalon and the zona limitans intrathalamica (zli) [5,6]. An
enhancer trap assay—using BAC transgenes to screen the Shh regulatory
region—identified SBE2, SBE3 and SBE4 that drive Shh expression in the
diencephalon (SBE2) and in the telencephalon (SBE4) [7]. Most recently, a
combined informatics and experimental study identified SBE5 that drives
expression in the zli [13].
Perturbation of Shh cis-regulation leads to severe neural defects in mammals.
Translocations separating SBE2, 3 and/or 4 from Shh, disrupt the function of
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Figure 1. The sonic hedgehog (Shh) regulatory region. (a) Cartoon shows the sites of Shh enhancer activity in the E11.5 mouse embryo. Sites of Shh expression in
the forebrain (telencephalon, diencephalon), caudal diencephalon, zli and midbrain/mesencephalon, floor plate, epithelial linings of gut and lung, and the distal
limb bud are indicated with different colours. (b) Genomic map of the Shh regulatory region on mouse chromosome 5 indicating the known tissue-specific Shh
enhancers, colour-coded as in (a).
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diverse holoprosecencephaly (HPE) phenotypes [14,15], point
mutation that results in the loss of SBE2 activity in the hypo-
thalamus also leads to HPE [16]. Together, these observations
highlight the importance of reporting and understanding new
cis-regulatory elements that control Shh expression in the CNS.
Using chromatin profiling during the in vitro differen-
tiation of mouse embryonic stem cells (mESCs) to neural
progenitor cells (NPCs), we report a new Shh brain enhancer
(SBE6) that we show is necessary for proper Shh expression in
NPCs and that is active in vertebrate brain and neural tube
development in transgenic assays.2. Material and methods
2.1. Cell culture and neural differentiation
46c mouse embryonic stem cells (mESCs), derived from
E14tg2A, contain a GFP insertion into the Sox1 locus [17].
mESCs were cultured and differentiated into NPCs for 5 or
7 days with N2B27 medium as described previously [18].
To sort GFPþ cells after transfection or differentiation, cells
were trypsinized and resuspended in PBS þ 10% medium.
Flow cytometric analysis was performed, using the 488 nm
laser of a BD FACSAriaII SORP (Becton Dickinson) with
525/50 nm bandpass filters. BD FACSDIVA software (Becton
Dickinson, v. 6.1.2) was used for instrument control and
data analysis.2.2. Quantitative analysis of gene expression
RNAwas prepared from approximately 1  106 46c mESCs or
NPCs, using the RNeasy mini kit (Qiagen) according to the
manufacturer’s protocol, including a DNaseI (Qiagen) treat-
ment for 15 min at room temperature. cDNA was
synthesized from 2 mg purified RNA with superscript II
reverse transcriptase (Invitrogen) primedwith random hexam-
ers (Promega). Real-time (q)PCR was carried out on a Roche
LightCycler 480 real-time PCR system, using a LightCycler
480 Sybr Green detection kit (Roche) as described previously
[19]. Primer pairs for qRT-PCR are listed in electronic
supplementary material, table S1.
The real-time thermal cycler was programmed as follows:
15 min Hotstart; 44 PCR cycles (958C for 15 s, 558C for 30 s,
728C for 30 s). The relative mRNA expression for each
primer set in each sample was measured by the LIGHTCYCLER
software and normalized to the mean for Gapdh from at least
two biological replicates and technical triplicates.
2.3. Native chromatin immunoprecipitation and
microarray analysis
Nuclei from 3  106 mESCs or sorted Sox1þ NPCs were pre-
pared and resuspended in NB-R (85 mM NaCl, 5.5% sucrose,
10 mM Tris–HCl pH 7.5, 3 mM MgCl2, 1.5 mM CaCl2,
0.2 mMPMSF, 1 mMDTT) as previously described [20].Micro-
coccal nuclease (MNase) digestion and native chromatin
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described [21,22]. Antibodies used for ChIP were H3K4me1
(Abcam ab8895) and H3K27ac (Millipore 07-360).
Ten nanograms (optimal) of input or ChIP DNA were
amplified, using the WGA2 whole genome amplification kit
(Sigma). Amplified material was labelled with Cy3 or Cy5
by random priming according to the NimbleGen ChIP-chip pro-
tocol (Roche). In total, two or three biological replicates with dye
swaps were hybridized for 20 h and washed according to the
manufacturer’s protocol. A custom 3  720 K mouse tiling
array (NimbleGen, Roche) containing 179 493 unique probes
from different genomic regions was used, with each probe
representedby four replicates.Arrayswere scannedonaNimble-
GenMS200Microarray scanner (Roche), using 100% laser power
and 2 mmresolution. Raw signal intensitieswere quantified from
TIFF images, using MS 200 DATACOLLECTION software.
Microarray datawere analysed in R, using the bioconductor
packages BEADARRAY and LIMMA according to the Epigenesys
NimbleGen ChIP-on-chip protocol 43 (www.epigenesys.eu/
en/protocols/bioinformatics). Scale normalization was used
within replicates, to control interarray variability. Each condi-
tion was represented by two biological replicates hybridized
as dye swap experiments and enrichment scores are defined
as log2 ChIP/input signal.
2.4. Computational analysis of the SBE6 region
Evolutionary conservation of the SBE6 region was assessed,
using the ‘Vertebrate Multiz Alignment & Conservation/
Multiz Alignments and Conserved Elements’ tracks in the
UCSC genome browser [23]. This delineated the following
subregions for further analysis:
SBE6.1: Chr5: 28 889 688–28 890 461, SBE6.2: Chr5:
28 893 935–28 895 000 (mm9)
RVISTA [24] was used to align the mouse and human
orthologous sequences, with the default sequence aligner
(LAGAN) and default parameters. Transcription factor bind-
ing sites (TFBS) for known forebrain transcription factors [25]
available on the RVISTA server were selected (Arx, Maf, Dlx5,
Pbx1, ER81, Six3, Vax1).
JASPAR [26] was used independently on the mouse and
human core sequences, searching for potential neural activity
present in the Jaspar Core Vertebrata matrices list (DLX6,
PBX1, ETV1, Six3, SP8 and VAX1) with the default par-
ameters (relative profile score threshold 80%; electronic
supplementary material, table S2). Hits were then highlighted
on the RVISTA alignment.
2.5. Zebrafish enhancer reporter assay
The putative SBE6.1 and SBE6.2 enhancers were cloned by
PCR amplification of the relevant fragment and flanking
sequence from mouse genomic DNA, using Phusion high
fidelity polymerase (NEB) and the following primers:
Sbe6.1 Fw B4 : AGGGGAGAACTTTGTATAGAAAAGTTG
GCGCGCCCACCTGCTTCTCTGAGGAA
Sbe6.1 Rv B1R : AGGGGACTGCTTTTTTGTACAAACTTG
CTTAGGCCATTGTGCCCAC
Sbe6.2 Fw B4 : AGGGGAGAACTTTGTATAGAAAAGTT
GGCGCGCTGAAGTCAAGGGCCTGGTACT
Sbe6.2 Rv B1R : AGGGGACTGCTTTTTTGTACAAACT
TGATCAGCCCTCCAGTTTGACTNegative controls used were sequences 30 of Shh, which have
no suspected regulatory activity, and which are the same
genomic distance from Shh as SBE6.1 and SBE6.2 are
upstream (50) of Shh.
Negative controls:
Sbe6.1 Fw B4: AGGGGAGAACTTTGTATAGAAAAGTT
GGCGCGCCGAGTGCAGGTGTTTGTGAA
Sbe6.1 Rv B1R: AGGGGACTGCTTTTTTGTACAAACTT
GCCTCAACACAGCATTGCCAA
Sbe6.2 Fw B4: AGGGGAGAACTTTGTATAGAAAAGTT
GGCGCGCAGAGAGTGAAGATTCCCAGCT
Sbe6.2 Rv B1R: AGGGGACTGCTTTTTTGTACAAACTT
GTGAGGCAGTGTCTATCTTTTGAC
attB4 and attB1r sequences (bold) were included in the PCR
primers for use with the Gateway recombination cloning
system (Invitrogen, 12538120). The amplified fragment was
first cloned into the Gateway pP4P1r entry vector and
sequenced usingM13 forward and reverse primers for verifica-
tion. The elements in the pP4P1r vector were combined with a
pDONR221 construct containing either a Gata2 promoter-
eGFP- polyA or a Gata2 promoter mCherry-polyA cassette
[27], and recombined into a destination vector with a Gateway
R4-R2 cassette flanked by Tol2 recombination sites.
Reporter plasmids were isolated using Qiagen miniprep
columns and were further purified using a Qiagen PCR purifi-
cation column (Qiagen), and diluted to 50 ng ml21 with
DNAse/RNAse free water. Tol2 transposase RNA was syn-
thesized from a NotI-linearized pCS2-TP plasmid using the
SP6 mMessage mMachine kit (Ambion), and similarly diluted
to 50 ng ml21. Equal volumes of the reporter construct(s) and
the transposase RNA were mixed immediately prior to injec-
tions. 1–2 nl of the solution was microinjected per zebrafish
embryo at the one- to two-cell stage for up to 200 embryos.
Embryos were screened for fluorescence at 1–5 days post-
fertilization (i.e. 24–120 hours post-fertilization, hpf) and
raised to adulthood. Germline transmission was identified by
mating of sexuallymature adults towild-type fish and examin-
ing their progeny for fluorescence. F1 embryos from three to
five F0 lines showing the best representative expression pattern
for each construct were selected for confocal imaging. A few
positive embryos were also raised to adulthood, and F1 lines
were maintained by outcrossing. A summary of the indepen-
dent lines analysed for each construct and their expression
sites is included in electronic supplementary material, table
S3. Imaging of zebrafish reporter transgenic embryos was
carried out as previously described [27].
2.6. Mouse transgenic reporter assays
The same SBE6.1 PCR amplicon, with attB4 and attB1r
sequences included as used for reporter assays in zebrafish
(above), were used to generate enhancer-reporter constructs
for mouse transgene assays. The amplicon was cloned directly
into an hsp68-LacZ vector containing a P4-P1r entry cassette
[28]. Transgenic mice were generated by microinjection into
mouse oocytes, and the analysis of transgenic lines was carried
out as previously described [28]. Two independently derived
E11.5 SBE6.1-LacZ embryos were independently analysed;
one a transient insertion, the second from a stable line. For
analysis, embryos were dissected in PBS and left in LacZ fix
for 1 h (1% formaldehyde; 0.2% glutaraldehyde; 2 mM
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embryos were washed in PBS containing 0.02% NP-40, before
being stained overnight at 378C in the dark in a solution con-
taining 5 mM K3Fe(CN)6; 5 mM K4Fe(CN)6.3H2O; 2 mM
MgCl2; 0.01% sodium deoxycholate; 0.02% NP-40 and
0.1% 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-
gal). Embryoswere then fixedwith 4%PFA and photographed
on a Leica MZ FLIII Microscope fitted with a Hamamatsu
Orca-ER digital camera and a CRI microcolour filter.
2.7. mRNA in situ hybridization
RNA in situ hybridization on fish embryos was performed as
previously described [29]. The sequences of primers used for
synthesis of Shh hybridization probes are the following:
Forward primer (50-SP6 promoter-sequence-30) AAGCT
GACACCTCTCGCCTA and reverse primer (50-T7 promoter-
sequence-30) GAGCAATGAATGTGGGCTTT.
Mouse in situ hybridization was performed with DIG-
labelled gene-specific antisense probes as previously described
[30]. The Shh probe was provided by McMahon [31].
2.8. Deletion of SBE6 from the 46c embryonic stem cell
genome
Cell line deletions were produced, using the Crispr/cas9
system. SBE6.1- and SBE6.2-specific gRNA primers (electronic
supplementary material, table S4) were cloned into the cas9
plasmid pX458 following protocols from the Zhang laboratory
[32–34]. 46C mESCs were transfected with the resulting
plasmids using Lipofectamine 2000 reagent (Invitrogen cat.
no. 11668) following the manufacturer’s recommendations as
described in [19]. Single transfected cells were sorted based on
GFP expression from pX458 and cultured further. DNA extrac-
tion and genotyping were performed 7 days after sorting, using
overnight incubation at 558C with lysis buffer (10 mM TrisHCl
pH 7.5, 10 mM EDTA, 10 mM NaCl, 0.5% SDS, 1 mg ml21
ProteinaseK) followed by ethanol precipitation and washes.
Genomic DNAwas amplified with the following primers:
SBE6.1 Fw: TTTTGGAAGCTTAAATGCCCAT
SBE6.1 Rv: CCACCACAAGCACATTCAT
SBE6.2 Fw: GCCTCCATGAAGTCCAATGG
SBE6.2 Rv: CCACCCTTGCTACTCAGGAA
Amplification was done using DreamTaq Green PCR master
mix (ThermoFisher K1081) following the manufacturer’s
protocol and PCR products were assessed by agarose gel elec-
trophoresis. Amplified products were later sequenced to
further confirm homozygous deletions.
3. Results
3.1. SBE6.1 and SBE6.2, two new putative
cis-regulatory elements active in neural
progenitor cells
We used the differentiation of 46c mESCs as a model system
to identify putative regulatory elements that may become
activated concomitant with the expression of Shh during
neural differentiation. These cells contain a knockin of GFP
into the Sox1 locus allowing for the monitoring of neuraldifferentiation and the purification, by fluorescence-activated
cell sorting (FACS), of Sox1þ neuroepithelial progenitor cells
(NPCs; figure 2a) [17,35,36]. Sox1þ cells appear after day 3 of
differentiation, and from day 3 to 7, expression of Shh and
Nestin increase whileOct4mRNA levels progressively decrease
(figure 2b). Analysis of these NPC cells for expression of mar-
kers from different regions of the developing brain (figure 2c)
suggests that these cells do not have a distinct regional identity,
though there is some evidence for a slight shift towards a more
telencephalic fate (increasing Six3 and Emx2 expression) and
away from the hindbrain (decreasing En2 andGbx2 expression)
by day 7 (figure 2d).
Genome-wide ChIP has allowed the identification of sev-
eral post-translational histone modification characteristics of
active enhancers including H3K4me1 and H3K27ac [37]. The
use of these two histone marks is widely employed to identify
new active enhancer elements in the genome [38], though they
are not comprehensive [18,39]. Using native ChIP coupled to
hybridization on microarrays (ChIP-chip) that tile the whole
Shh regulatory region, we assessed the sites of enriched
H3K4me1 andH3K27ac inmESCs (where Shh is not expressed)
and in Sox1þ NPC after 5 days of neural differentiation. Sig-
nificant gains of H3K4me1 and H3K27ac were not detected
at the known SBE2, 3, 4 or 5 brain enhancers (figure 3a).
However, a prominent change in the ChIP profile was seen at
a small region approximately 100 kb upstream of the Shh
TSS. This region has no evidence of active enhancer marks in
mESCs but gains both H3K4me1 and H3K27ac upon neural
differentiation (figure 3a).
Analysis of sequence conservation across multiple ver-
tebrate species indicated that this region contains two blocks
of evolutionary conservation in mammals and birds, and we
named these putative NPC enhancers SBE6.1 (mm9 coordi-
nates Chr5: 28 889 688–28 890 461, 96 048 bp upstream of Shh
TSS) and SBE6.2 (Chr5: 28 893 935–28 895 000, 100 295 bp
away from Shh; figure 3b). Interestingly, two other sequences
beyond SBE3 also show a gain of active enhancer marks
(arrowheads in figure 3a), but are not investigated further here.
In silico motif analysis using UCSC comparative geno-
mics of SBE6.1 and SBE6.2 allowed us to identify two core
(approx. 1 kb) regions that are highly conserved. Comp-
lementary RVISTA, JASPAR and RSAT scans of those regions
revealed the presence of predicted binding sites for neural
transcription factors such as ETV1, SP8, VAX1 and DLX6
(electronic supplementary material, table S2).
The SBE6.1 sequence is entirely included in a recently
described 1.7 kb lung and gut epithelium regulatory ele-
ment for Shh expression in mouse embryos called SLGE
(chr5: 28 889 230–28 890 979) [40], raising the possibility
either that this enhancer has multiple regulatory activities or
that SLGE is ectopically activated in NPCs. SBE6.2 has not
previously been identified or studied.3.2. SBE6.1 drives expression in the brain of developing
zebrafish and mouse embryos
To test the regulatory potential of SBE6.1 and SBE6.2, we used a
zebrafish Tol2 transposon assay inwhich the test element is jux-
taposed to a minimal promoter driving the expression of either
GFP or mCherry reporter gene expression. This assay has been
shown to recapitulate the correct expression pattern for the
SBE2 enhancer and to detect the loss of this enhancer activity
Sox1-GFP–
embryonic stem cells (ESCs)
Sox1-GFP+
neural progenitors cells (NPCs)
Fgf5Oct4
ESC prim ectoderm neuroectoderm
Sox1
N2B27
lo
g 2
 
m
R
N
A
 le
v
el
s r
el
at
iv
e 
to
 E
SC
lo
g 2
 
m
R
N
A
 le
v
el
s r
el
at
iv
e 
to
 E
SC
lo
g 2
 
m
R
N
A
 le
v
el
s r
el
at
iv
e 
to
 E
SC
NPC
–10
–5
0
5
10
15
ESC ESCday 5 day 7
0ct4
day 5 day 7
Nestin
NPC
ESC day 5 day 7
Shh
NPC
Irx3
Tcf4
En2
Gbx2Shh
Six3
Foxg1
Emx2
Tel
Di Mes
Met
Foxg1Six3
–5
0
5
10
15 Emx2
–5
0
5
10
15 Tcf4 Irx3 Gbx2En2
*
NPC
ESC day 5 day 7 ESC day 5 day 7
NPC
ESC day 5 day 7
NPC
NPC
ESC day 5 day 7 ESC day 5 day 7
NPC
ESC day 5 day 7
NPC
ESC day 5 day 7
NPC
(b)(a)
(c)
(d )
Figure 2. Sox1-GFPþ neural differentiation from ESC to NPCs. (a) Schematic shows the differentiation of 46c mouse embryonic stem cells (ESC)—which are Sox1-
GFP– and express high levels of the pluripotency factor Oct4—into first primitive ectoderm as Oct4 levels decrease and fibroblast growth factor 5 (Fgf5) levels rise,
and then further into neuroectoderm as Fgf5 levels start to decrease and Sox1 levels rise, allows for the purification of Sox1-GFPþ neural progenitor cells (NPC). (b)
qRT-PCR showing mean+ s.e. of the mean (s.e.m.) log2 mRNA levels for Oct4, Nestin and Shh in ESCs and in NPCs after 5 and 7 days of differentiation. Expression
levels are relative to Gapdh and normalized to ESC mRNA levels. Data are from three biological replicates and technical triplicates. (c) Schematic of an E11.5 mouse
brain and gene expression markers patterning the telencephalon (tel), diencephalon (di), mesencephalon (mes) and metencephalon (met). (d ) qRT-PCR shows
means (+s.e.m.) of log2 mRNA levels of marker genes for different brain regions in ESC and NPC differentiated for 5 or 7 days. As in (b), levels are relative
to Gapdh and normalized to ESC mRNA levels. Six3 mRNA levels significantly increase in NPCs between days 5 and 7 of differentiation (one-tailed Student’s
t-test; p ¼ 0.023). Data consist of five biological replicates and technical triplicates.
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cases of HPE [16,27]. In situ hybridization for Shh mRNA in
wild-type zebrafish embryos reveals expression in the forebrain
at 48 and 72 hpf [27]. Using this assay, SBE6.1 enhancer activity
was detected in the developing forebrain of the zebrafish
embryos in four independent stable transgenic lines from 30
to 72 hpf (figure 4a,b; electronic supplementary material, table
S3). SBE6.2 however failed to consistently drive reporter gene
expression in the forebrain, with forebrain-specific activity
noted in only one out of the four independent transgenic lines
generated (electronic supplementary material, table S3). There-
fore, SBE6.1 has a consistent enhancer function and is active in
zebrafish forebrain development.
The ability of SLGE to drive expression in the developing
mouse brain is unclear, but it is known to be capable of driving
expression in the brain of transgenic rabbits [40]. We therefore
made mouse transgenics to analyse the regulatory potential of
SBE6.1 in mouse development. LacZ staining of transient and
stable SBE6.1 transgenic embryos revealed activity in the phar-
yngeal endoderm, gut and cloaca of the mouse embryo as
expected owing to the overlap with SLGE (electronic sup-
plementary material, figure S1a,b). X-gal staining could
be also detected in few superficial diencephalon cells whereShh is not expressed (figure 4c; electronic supplementary
material, figure S1c). However, SBE6.1 also showed activity
in the developing ventral mesencephalon with some cells
expressing SBE6-LacZ near the hindbrain and as well as in
the ventral midline of the mouse embryonic neural tube—all
sites of endogenous Shh expression (figure 4d,e; electronic
supplementary material, figure S1d).
SBE6.1 is only active in a small number of cells in transgenic
embryos, and we cannot at this stage confirm how accurately
this recapitulates a subset of endogeneousShh expression.How-
ever, the strong similarities between the twomouse embryos do
support our conclusion that the SBE6.1 enhancer is capable of
activity in the developing vertebrate brain, from a forebrain pat-
tern in zebrafish transgenics to a floor plate and ventral
mesencephalon expression in mouse transgenic embryos.3.3. SBE6.1 enhances Shh expression in neural
progenitor cells
To determine the regulatory activity of SBE6.1 and SBE6.2 in
their native context, we used CRISPR/Cas9 to delete these
elements from the genome in 46c mESCs (SBE6.12/2 and
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Figure 3. Chromatin immunoprecipitation analysis during NPC differentiation. (a) Log2 native ChIP/input MNase-digested chromatin for H3K4me1 (black) and H3K27ac
(grey) from ESCs and Sox1þ NPCs purified after 5 days of differentiation. Averages of data from two biological replicates are shown. The position of genes (above) and
known neural enhancers for Shh (below) are shown; grey arrow indicates the new candidate neural enhancer SBE6; grey arrowheads indicate two other regions that gain
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generated and analysed two SBE6.12/2 and three SBE6.22/2
independent cell lines. Upon NPC differentiation, the pro-
portion of Sox1-GFPþ cells remained the same between
NPCs derived from wild-type and SBE6.12/2 or SBE6.22/2
cells, analysis of Oct4 and NestinmRNA expression confirmed
that differentiation of mESCs into NPC was not perturbed by
the loss of either SBE6.1 or SBE6.2 (figure 5a). However, in
NPCs derived from SBE6.12/2 but not SBE6.22/2 cells,
levels of Shh expression were significantly reduced compared
with wild-type cells (one-tailed Student’s t-test; p ¼ 0.002).
Average Shh mRNA levels in NPCs differentiated fromSBE6.22/2 ESCs were not significantly different relative to
wild-type (figure 5b).
Together, these data suggest that SBE6.1 is a long-range
enhancer that contributes to driving Shh expression during
the differentiation of ESCs to neural progenitor cells.4. Discussion
The regulation of Shh is a paradigm for the complex control of
gene expression at different times and places in development.
More than 10 discrete enhancers have been identified in the
48 hpf 72 hpf
48 hpf 72 hpf
FB
FB
FB
ventral
ventral
dorsal
dorsal
RH CH RH
SBE6.1-eGFP
SBE6.2-mCherry
FB
RH
Shh in situ
48 hpf
FB
ventral
RH CH
72 hpf
FB
dorsal
RH
SBE6.1-LacZ E11.5
Shh in situ SBE6.1-LacZ SBE6.1-LacZ
(b)(a)
(c)
(d ) (i) (ii) (e)
HB
MB
FB
zli
Figure 4. Enhancer reporter assays for SBE6.1 and SBE6.2. (a) Shh mRNA in situ hybridization on zebrafish embryos. A ventral view is shown at 48 h post-fertilization
(hpf ) and a dorsal view at 72 hpf. Shh expression is detected in the rostral hypothalamus (RH) and caudal hypothalamus (CH) of the forebrain (FB). (b) Confocal
microscopy of 48 and 72 hpf zebrafish embryos from stable transgenic lines carrying a Tol2 transposon with SBE6.1 and SBE6.2, driving GFP and mCherry, respect-
ively. Reporter gene expression is detected in the rostral hypothalamus (RH) and caudal hypothalamus (CH) of the forebrain (FB). (c) External view of the LacZ
staining in a stable SBE6.1 transgenic E11.5 embryos shows expression in a portion of diencephalon cells. (d ) (i) Shh mRNA in situ hybridization in an E11.5 mouse
embryo displaying expression in the forebrain (telencephalon, diencephalon; FB), midbrain (caudal diencephalon, zona limitans intrathalamica (zli) and mesen-
cephalon; MB), and hindbrain (HB). (ii) sagittal section of an E11.5 transient SBE6.1-LacZ transgenic embryo with arrowhead indicating staining in a portion
of the ventral mesencephalon, with some cells expressing SBE6.1 near the hindbrain. (e) E11.5 transient SBE6.1-LacZ transgenic embryo with arrowhead indicating
staining in the floor plate of the spinal cord.
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Most of these enhancers were identified using transgenic
reporter assays [7]. Others have been identified through gen-
etics in mouse and man when mutations in Shh enhancers
cause phenotypes that result from aberrant control of specific
aspects of Shh expression in development. Most recently,
information on transcription factor motifs in known Shh
brain enhancers has been used to search for other similar
patterns of motifs in the Shh regulatory domain and has
identified a new enhancer that drives Shh expression in a
discrete region of the brain [7,13].
Here, we show that analysis of histone modifications
(H3K4me1 and H3K27ac), typically associated with active
enhancers, in an in vitro neural differentiation system canbe used to identify a new enhancer that is important for the
activation of Shh in neural progenitor cells. This enhancer,
which we have named SBE6, is located 100 kb 50 of Shh and
is activated during the differentiation of mESCs to Sox1þ
NPCs. Analysis of transcription factor motifs suggests that
SBE6 contains consensus binding sites for a number of tran-
scription factors expressed in the brain. Using an enhancer
reporter assay in zebrafish and mouse, we show that in vivo
the SBE6.1 region of SBE6, but not SBE6.2, can drive
expression in the developing brain. Consistent with this, gen-
etic ablation of SBE6.1 in mESCs, but not SBE6.2, abrogates
the induction of Shh expression during in vitro NPC differen-
tiation. Therefore, despite the presence of strong active
enhancer histone modifications in NPCs, we find no
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Figure 5. Shh expression levels in neural precursor cells (NPC) derived from ESC lines with SBE6.1 or SBE6.2 deletions. (a) qRT-PCR shows mean (+s.e.m.) log2 mRNA
levels of Oct4 and Nestin in wild-type 46c ESC, and NPCs, and in NPCs derived from SBE6.12/2 (left) or SBE6.22/2 (right) 46c cells. Levels are relative to Gapdh and
normalized to levels in wild-type ESCs. (b) As in (a) qRT-PCR shows mean (+ s.e.m.) log2 Shh mRNA levels in wild-type NPCs, and in NPCs derived from 46c cell lines
deleted for SBE6.1 (left) or SBE6.2 (right). mRNA levels are shown relative to Gapdh and normalized to those in wild-type ESCs. Shh mRNA levels are significantly reduced
in NPCs derived from SBE6.12/2 cell lines after 7 days of differentiation (one-tailed Student’s t-test; p-value ¼ 0.002). ESC data consist of three biological replicates,
SBE6.12/2 dataset are six biological replicates from two independent deletion cell lines compared with six biological replicates of wild-type (WT) NPC. SBE6.22/2 data
are from three biological replicates from three independent deletion cell lines with three biological replicates of wild-type (WT) NPCs.
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lighting that precise annotation and understanding of
regulatory regions of the genome requires confirmation via
functional enhancer assays.
Our analyses presented here add to the growing number of
functionally validated enhancers directing Shh expression in
different developmental contexts. Given the large size of the
gene desert upstream of Shh, where many of these enhancers
are located, there is the potential for this region to harbour
many more cis-regulatory elements and, given the complexity
of brain development, many of these may be enhancers active
in the brain. Indeed, regulatory segmentation built from
ChromHMM or Segway using ENCODE data from various
mouse primary tissues indicates the presence of several regions
with chromatin signatures indicative of enhancer activity in
mouse brain at E14.5—a period of mouse development when
neurogenesis is ongoing (figure 6a). This includes the genomic
regions containing the known neural enhancers SBE2–4, but
also a region that corresponds to SBE6. The many other regions
called as likely active enhancers using the analysis from just
four tissues (brain, liver, spleen and kidney) at one embryonic
stage (figure 6a) suggests that the Shh regulatory region may
harbour many tens of as yet unannotated enhancers. We note
that the new sites detected by these high-throughput methods
(markedwith arrowheads as #1 and #2 in figure 6a) correspondto peaks of H3K4me1/H3K27ac that are induced during the
differentiation of 46c mESCs to NPCs (figures 3 and 6a; elec-
tronic supplementary material, figure S3). A similar analysis
of chromatin profiling data from the Roadmap project also indi-
cates the signature of an active neural enhancer at the position of
SBE6 in material from different regions of the human brain and
particularly in ganglionic eminence derived neurospheres
(figure 6b). This analysis also indicates many other potential
regulatory elements active in different brain regions.
It is interesting that the genome coordinates of SBE6.1 are
completely contained within those reported for the Shh lung
and gut epithelium regulatory element SLGE [40]. Transgenic
analysis in the rabbit had shown that the mouse SLGE frag-
ment can drive expression in the rabbit brain [40]. Here, we
have shown that SBE6.1 can drive expression in the brain of
zebrafish and mouse. Although we cannot completely exclude
that our observations of SBE6.1 transgenic reporter expression
in the vertebrate brain and neural tube represents ectopic
activity of SLGE in these assays, our chromatin profiling
indicates that this region does harbour active regulatory poten-
tial in Sox1þ NPCs. Consistent with this, ENCODE and
Roadmap data also indicate that this region of the mammalian
genome has active enhancer chromatin marks in neural tissue,
as well as in the liver (figure 6a; electronic supplementary
material, figure S3) and gastric tissue (figure 6b). Important
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Figure 6. Chromatin state discovery and characterization (ChromHMM) in mouse and human Shh regulatory region. (a) Ensembl Mus musculus v. 84.38
(GRCm38.p4) view of chr5: 28 456 840–29 050 000 with regulatory feature tracks form primary cells (embryonic E14.5 brain, and adult liver, spleen and
kidney) from ChromHMM. Grey arrowheads indicate previously described enhancers and two putative sequences (#1 and #2) indicated in figure 3. The position
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of transcription factor motifs [13]. SBE6.1 and SLGE motifs
may be intermingled but still specific to a precise tissue and
stage of development, or may be overlapping to various
extents. There are several other examples of regulatory
elements capable of driving expression at multiple sites
during development—for example, the global control region
50 of HoxD contains regulatory information capable of driving
expression in the CNS and in the limb [41].Moreover, for SOX9
and PAX6, there are cis-regulatory elements driving expression
in multiple developmental sites, and in which disease-
associated variants have been identified that ablate enhancer
function in one tissue but leave the other sites of expres-
sion unaltered [27,42]. Further analysis will be necessary to
determine the critical transcription factor binding sites in
SBE6.1/SLGE needed to drive enhancer function in different
developmental settings.
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